Loading Events

« All Events

  • This event has passed.

Genomic Imprinting – from Biology to Disease Virtual Conference

September 28 2020 @ 1:00 PM - October 1 2020 @ 5:00 PM

This conference aims at bringing together basic research scientists, health care professionals and others from different disciplines in order to share expertise in genomic imprinting and imprinting disorders and provide opportunities for cross-disciplinary collaborations.

Topics will include:

  • Epigenetics mechanisms and imprinting
  • Life Cycle of imprinting
  • Environment and imprinting
  • Inherited factors
  • Clinical aspects
  • Imprinting disorders and beyond
  • Techniques and sequencing

The conference is held in collaboration with the newly formed International Genomic Imprinting Society (IGIS).

The abstract deadline is 4th August 2020 and the registration deadline is 21st September 2020. Please see the Wellcome Genome Campus website for more information.

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.